A new website to aid finding scientific applications for iOS devices
As you probably know Apple are dropping support for MobileMe based websites and so I’ve had to move “Macs in Chemistry” to a new web host. I’ve taken the opportunity to clean up many of the links and pages but as you can imagine after nearly 10 years of posts using multiple packages to generate the pages it was getting a little untidy.
Here is the new Macs in Chemistry site http://www.macinchem.org
About the Author
WebGL, the HTML5 technology for native 3D graphics in browsers (without Java or other plugins), has arrived. This 3D ability allows scientists to create more interactive scientific and educational tools, cheaply and easily distributed through the web.
A couple of weeks ago I published a review of FieldView a molecular viewer/editor from Cresset that is designed to show molecules with their associated Field patterns and physicochemical properties.
I just noticed that Mobile MIM have got FDA approval for their remote medical diagnostic tool for the iPad and iPhone.
I think this is the first application to get FDA approval.
The ChemDoodle Web Components have been updated.
I’ve just added friedEgg Touch to the list of 60 data analysis tools available for Mac OS X.
ChemDoodle now supports round-trip editing with the latest update of Microsoft Office 2011 (14.0.1). So make sure you update your copies of Microsoft Office 2011, and round trip editing will be available again on Mac OS X!
Round-trip editing allows you to copy figures into another application from ChemDoodle and then paste those figures from that application back into ChemDoodle to recover the objects and edit them. You do not need to save an additional ChemDoodle file.
ChemDoodle also supports round-trip editing with other applications on Mac OS X, including Mail and iWork Keynote. We are working to provide further round-trip editing support with even more applications on Mac OS X.
With the introduction of Mac OS X 10.6 Applescript gained access to the Cocoa Frameworks, unfortunately there is very little information available on how to leverage this new found capability.